Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Viewpoints: 'Good news' on Calif. insurance rates; Battle against dementia needs stronger efforts; Dental care for the disabled

The Affordable Care Act, a k a Obamacare, goes fully into effect at the beginning of next year, and predictions of disaster are being heard far and wide. ... No doubt there will be problems, as there are with any large new government initiative, and in this case, we have the added complication that many Republican governors and legislators are doing all they can to sabotage reform. Yet important new evidence - especially from California, the law's most important test case - suggests that the real Obamacare shock will be one of unexpected success (Paul Krugman, 5/26).

29 May 2013

Protein presenilin plays critical role in controlling neuronal traffic on microtubule highways

Imagine if you could open up your brain and look inside. What you would see is a network of nerve cells called neurons, each with its own internal highway system for transporting essential materials between different parts of the cell.

29 May 2013

UCLA researchers show that bacteria ingested in food can affect brain function

UCLA researchers now have the first evidence that bacteria ingested in food can affect brain function in humans. In an early proof-of-concept study of healthy women, they found that women who regularly consumed beneficial bacteria known as probiotics through yogurt showed altered brain function, both while in a resting state and in response to an emotion-recognition task.

29 May 2013

Research discovery may lead to development of new therapies for neurological disorders

For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.

29 May 2013

Bay Pines VA Healthcare System to study effectiveness of 7-Keto compound in PTSD

The Bay Pines VA Healthcare System announced that it will begin a research study related to post-traumatic stress disorder. The study will focus on whether the use of a naturally occurring compound known as 7-Keto assists in the treatment of PTSD.

29 May 2013

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

A large analysis of more than 100 studies from around the world shows that exposure to pesticides, or bug and weed killers, and solvents is likely associated with a higher risk of developing Parkinson's disease. The research appears in the May 28, 2013, print issue of Neurology-, the medical journal of the American Academy of Neurology.

28 May 2013

New AAN guideline provides direction for use of blood thinners during surgery

A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures.

28 May 2013

More evidence of high oxidative stress levels found in Down syndrome neurons

Down syndrome, the most common genetic form of intellectual disability, results from an extra copy of one chromosome. Although people with Down syndrome experience intellectual difficulties and other problems, scientists have had trouble identifying why that extra chromosome causes such widespread effects.

28 May 2013

New animal model provides insight into early stages of Parkinson's disease

At the present, no cure exists for Parkinson's disease, although symptomatic intervention, including treatment with dopamine agonists, can alleviate patients' motor impairment. Parkinson's is the second most common neurodegenerative disorder, after Alzheimer's disease; it is estimated that 100,000 to 300,000 patients are affected by Parkinson's disease in Germany alone.

28 May 2013

Scientists question strategy to target critical protein in the brain to combat Alzheimer's disease

In the search for medication against Alzheimer's disease, scientists have focused - among other factors - on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the known plaques in the brains of Alzheimer's patients. Starting point for the formation of A-beta is APP. Alessia Soldano and Bassem Hassan (VIB/KU Leuven) were the first to unravel the function of APPL - the fruit-fly version of APP - in the brain of healthy fruit flies.

28 May 2013

Research: Anti-cancer drug tested as possible treatment for Alzheimer's disease proved ineffective

An anti-cancer drug about to be tested in a clinical trial by a biomedical company in Ohio as a possible treatment for Alzheimer's disease has failed to work with the same type of brain plaques that plague Alzheimer's patients, according to results of a study by University of Florida researchers.

24 May 2013

Georgia Tech and Emory University receive $4 million grant to establish HERCULES Center

Investigators at Rollins School of Public Health at Emory University, along with partners at the Georgia Institute of Technology, have received a $4 million grant over four years to establish the HERCULES Center at Emory University (Health and Exposome Research Center: Understanding Lifetime Exposures). The grant is the first exposome-based center grant awarded in the United States.

24 May 2013

Smartphone solutions for clinical trials

mHealth broadly refers to the use of a mobile device to send patient information to or from a medical service provider. In most medication management mobile applications that are out there now, the “information” sent is usually a unidirectional nagging reminder to the patient. The application may populate a diary or it may not.

24 May 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Viewpoints: 'Good news' on Calif. insurance rates; Battle against dementia needs stronger efforts; Dental care for the disabled

Protein presenilin plays critical role in controlling neuronal traffic on microtubule highways

UCLA researchers show that bacteria ingested in food can affect brain function

Research discovery may lead to development of new therapies for neurological disorders

Bay Pines VA Healthcare System to study effectiveness of 7-Keto compound in PTSD

Exposure to bug or weed killers is associated with higher risk of Parkinson's disease

New AAN guideline provides direction for use of blood thinners during surgery

More evidence of high oxidative stress levels found in Down syndrome neurons

New animal model provides insight into early stages of Parkinson's disease

Scientists question strategy to target critical protein in the brain to combat Alzheimer's disease

Research: Anti-cancer drug tested as possible treatment for Alzheimer's disease proved ineffective

Georgia Tech and Emory University receive $4 million grant to establish HERCULES Center

Smartphone solutions for clinical trials

Caregivers experience less stress when family members with dementia attend ADS program

Researchers recommend that bexarotene should not be tested on Alzheimer's patients

Cinnamon compounds show some promise in the effort to fight Alzheimer's disease

Aortic arch pulse wave velocity predicts disease of the vessels that supply blood to the brain

Research finds number of links between dental health and overall health

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Alzheimer's disease: Researchers find new drug to prevent, treat the disease

Innovation in neuroscience drug discovery - eBook eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in